- Home
- Insider Trading Stock Activity
- Waltermire Robert E.
Stock Insider Trading Activity of Waltermire Robert E.
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$340.42
Shares
14,113
Total Value
$4,817,103.60
Owned After
15,164
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$341.27
Shares
1,227
Total Value
$418,488.05
Owned After
15,164
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$335.24
Shares
103
Total Value
$34,529.72
Owned After
15,164
SEC Form 4
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$273.41
Shares
442
Total Value
$120,847.22
Owned After
15,164
SEC Form 4
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$280.00
Shares
1,900
Total Value
$532,000.00
Owned After
15,164
SEC Form 4
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$285.00
Shares
2,000
Total Value
$570,000.00
Owned After
15,164
SEC Form 4
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$231.34
Shares
1,036
Total Value
$239,668.24
Owned After
15,164
SEC Form 4
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$235.50
Shares
4,000
Total Value
$942,000.00
Owned After
15,164
Senior VP, Chief Pharma Dev.
Avg Cost/Share
$221.50
Shares
3,800
Total Value
$846,700.00
Owned After
15,164
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Mar 5, 2025 | Sell | $340.42 | 14,113 | $4,817,103.60 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Feb 28, 2025 | Sell | $341.27 | 1,227 | $418,488.05 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Jan 24, 2025 | Sell | $335.24 | 103 | $34,529.72 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Jan 17, 2025 | Sell | $273.41 | 442 | $120,847.22 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Jun 14, 2024 | Sell | $280.00 | 1,900 | $532,000.00 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Jun 12, 2024 | Sell | $285.00 | 2,000 | $570,000.00 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | May 21, 2024 | Sell | $231.34 | 1,036 | $239,668.24 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Dec 14, 2023 | Sell | $235.50 | 4,000 | $942,000.00 | 15,164 | |
| Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Dec 12, 2023 | Sell | $221.50 | 3,800 | $846,700.00 | 15,164 |